Cel-Sci’s arthritis vaccine ‘reprogramming’ the immune system 29-May-2019 By Vassia Barba Cel-Sci’s rheumatoid arthritis treatment, developed under an $1.5m NIH grant, will be featured at the BIO Convention in Philadelphia next week.